Rep. Brett Guthrie

R

Kentucky – District 2
representative

Leadership

Chairman

119th Congress

News & Announcements

Feb 10, 2026
Press Release

CMT Subcommittee Forwards Motor Vehicle Safety and Automotive Leadership Bills to Full Committee

WASHINGTON, D.C. – Today, Congressman Gus Bilirakis (FL-12), Chairman of the Subcommittee on Commerce, Manufacturing, and Trade, led a markup of twelve bills to strengthen automotive safety, affordability, and leadership.

“The twelve bills we considered address a wide range of priorities from improving vehicle safety technology to modernizing our transportation regulations. Each of these measures reflects a commitment to keeping Americans safe on the road, while supporting the competitiveness and innovation of our domestic automotive industry,” said Chairman Bilirakis. “Ensuring safe, affordable, and reliable transportation is critical for families, businesses, and communities alike, and today’s markup is another step toward saving lives and preparing our automotive industry for the challenges and opportunities of the future.”

Legislative Vote Summary:

  • H.R. 1566, Right to Equitable and Professional Auto Industry Repair (REPAIR) Act, was forwarded to the Full Committee by a voice vote.
  • H.R. 7390, Safely Ensuring Lives Future Deployment and Research In Vehicle Evolution (SELF DRIVE) Act of 2026, was forwarded to the Full Committee by a roll call vote of 12 yeas – 11 nays.
  • H.R. 7389, Motor Vehicle Modernization Act of 2026, was forwarded, as amended, to the Full Committee by a voice vote.
  • H.R. 5221, PART Act, was forwarded to the Full Committee by a voice vote.
  • H.R. 2110, Safe Vehicle Access for Survivors Act, was forwarded to the Full Committee by a voice vote.
  • H.R. 6688, ADAS Functionality and Integrity Act, was forwarded to the Full Committee by a voice vote.
  • H.R. 3360, Driver Technology and Pedestrian Safety Act, was forwarded, as amended, to the Full Committee by a voice vote.
  • H.R. 3385, To direct the Secretary of Transportation to issue certain regulations to update the definition of motorcycle, and for other purposes, was forwarded to the Full Committee by a voice vote.
  • H.R. 7372, Safety Is Not for Sale Act, was forwarded to the Full Committee by a voice vote.
  • H.R. 7377, Know Before You Drive Act, was forwarded to the Full Committee by a voice vote.
  • H.R. 6947, Securing Accessible Functional Emergency (SAFE) Exit Act of 2026, was forwarded to the Full Committee by a voice vote.
  • H.R. 7353, Magnus White and Safe Streets for Everyone Act of 2026, was forwarded to the Full Committee by a voice vote.

Watch the full markup here.

Below are key excerpts from today’s markup:

BV8A1953 copy.JPG

Congressman Craig Goldman (TX-12) on H.R. 7390, the Safely Ensuring Lives Future Deployment and Research In Vehicle Evolution (SELF DRIVE) Act of 2026: “The SELF DRIVE Act takes a clear approach to regulating autonomous vehicles by pairing innovation with clear, enforceable safety expectations. […] A chaotic web of over 30 state laws breeds confusion, stalls deployment, undermines consistent safety, and erodes consumer confidence. The SELF DRIVE Act cuts through this red tape with a unified national framework, unleashing innovation nationwide.”

BV8A1794 copy.JPG

Chairman Brett Guthrie (KY-02) on H.R. 7389, the Motor Vehicle Modernization Act of 2026: “Our primary tasks here today are to strengthen motor vehicle safety, modernize, and unlock innovation in the automotive industry. The Motor Vehicle Modernization Act advances all three of these objectives.”

BV8A2032 copy.JPG

Congressman Gabe Evans (CO-08) on H.R. 5221, the PART Act: “Law enforcement groups have gone on the record to state that including tracing in legislation is critical to helping deter the theft and trafficking of stolen catalytic converters, making it easier to prosecute the criminals committing these crimes. […] My constituents deserve real solutions, which the PART Act helps to deliver with a national framework to combat catalytic converter theft.”

Feb 6, 2026
Press Release

Trump Administration Secures Victory for American Patients as FTC Crackdown Ends Predatory Practices of Major PBM

WASHINGTON, D.C. – Just one day after President Trump signed into law the most comprehensive pharmacy benefit manger (PBM) reform in American history, the Federal Trade Commission (FTC) reached a historic settlement with one of the nation’s largest PBMs, Express Scripts, Inc., along with affiliated entities (ESI collectively), requiring them to change current business practices to drive down drug costs for patients and employers.

The settlement directly addresses many of the harmful pharmaceutical middlemen practices that the House Committee on Energy and Commerce has called attention to for years and supports a key commitment of President Trump’s new health care agenda, The Great Healthcare Plan, to lower prescription drug prices.

Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, issued the following statement:

“This week has marked many successes when it comes to transparency and affordability of prescription drugs for American patients,” said Chairman Guthrie. “The House Committee on Energy and Commerce supports President Trump’s efforts and will continue this work by calling in representatives across the entire prescription drug supply chain next week to continue our commitment to lowering the cost of care for all Americans. This is just another way Republicans are working to implement meaningful relief for American families when it comes to health care affordability.”

Background:

ESI, under the FTC’s proposed consent order, has agreed to:

  • Stop preferring on its standard formularies high wholesale acquisition cost versions of a drug over identical low wholesale acquisition cost versions;
  • Provide a standard offering to its plan sponsors that ensures that members’ out-of-pocket expenses will be based on the drug’s net cost, rather than its artificially inflated list price;
  • Provide covered access to TrumpRx as part of its standard offering upon relevant legal and regulatory changes;
  • Provide full access to its Patient Assurance Program’s insulin benefits to all members when a plan sponsor adopts a formulary that includes an insulin product covered by the Patient Assurance Program unless the plan sponsor opts out in writing;
  • Provide a standard offering to all plan sponsors that allows the plan sponsor to transition off rebate guarantees and spread pricing;
  • Delink drug manufacturers’ compensation to ESI from list prices as part of its standard offering;
  • Increase transparency for plan sponsors, including with mandatory, drug-level reporting, providing data to permit compliance with the Transparency in Coverage regulations, and disclosing payments to brokers representing plan sponsors;
  • Transition its standard offering to retail community pharmacies to a more transparent and fairer model based on the actual acquisition cost for a drug product plus a dispensing fee and additional compensation for non-dispensing services;
  • Promote the standard offerings to plan sponsors and retail community pharmacies; and
  • Reshore its group purchasing organization Ascent from Switzerland to the United States, which will bring back to the United States more than $750 billion in purchasing activity over the duration of the order.
  • The settlement is projected to ** save American patients $7 billion ** in out-of-pocket costs for prescription drugs over a decade.

Click HERE to read the full settlement.

Feb 6, 2026
Press Release

Chairmen Guthrie and Bilirakis Announce CMT Subcommittee Markup of Legislation to Strengthen Motor Vehicle Safety and Advance U.S. Automotive Leadership

WASHINGTON, D.C. – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman Gus Bilirakis (FL-12), Chairman of the Subcommittee on Commerce, Manufacturing, and Trade, announced a subcommittee markup of twelve bills to strengthen automotive safety, affordability, and leadership.

WHAT: Subcommittee on Commerce, Manufacturing, and Trade markup of twelve bills.

DATE: Tuesday, February 10, 2026

TIME: 10:15 AM ET

LOCATION: 2123 Rayburn House Office Building

Items to be considered:

  • H.R. 5221, PART Act (Reps. Baird and McCollum)
  • H.R. 2110, Safe Vehicle Access for Survivors Act (Reps. Dingell and Crenshaw)
  • H.R. 6688, ADAS Functionality and Integrity Act (Reps. Harshbarger, Obernolte, Vazquez, and Torres-CA)
  • H.R. 3360, Driver Technology and Pedestrian Safety Act (Rep. Mullin)
  • H.R. 3385, To direct the Secretary of Transportation to issue certain regulations to update the definition of motorcycle, and for other purposes. (Rep. Van Orden)
  • H.R. 1566, Right to Equitable and Professional Auto Industry Repair (REPAIR) Act (Reps. Dunn and Perez)
  • H.R. 7389, Motor Vehicle Modernization Act of 2026 (Chairman Guthrie)
  • H.R. 7390, Safely Ensuring Lives Future Deployment and Research In Vehicle Evolution (SELF DRIVE) Act of 2026 (Rep. Latta)
  • H.R. 7372, Safety Is Not for Sale Act (Ranking Member Pallone)
  • H.R. 7377, Know Before You Drive Act (Rep. Schrier)
  • H.R. 6947, Securing Accessible Functional Emergency (SAFE) Exit Act of 2026 (Rep. Kelly-IL)
  • H.R. 7353, Magnus White and Safe Streets for Everyone Act of 2026 (Rep. Clarke)

This notice is at the direction of the Chairman. The hearing will be open to the public and press and will be livestreamed online at energycommerce.house.gov. If you have any questions concerning this hearing, please contact Jackson Rudden at Jackson.Rudden@mail.house.gov. If you have any press-related questions, please contact Daniel Kelly at Daniel.Kelly@mail.house.gov.

Letters

Jan 13, 2026
Press Release

Chairmen Guthrie, Joyce, Griffith, Smith, Schweikert, and Buchanan Ask HHS OIG About Ongoing HHA and Hospice Fraud in Los Angeles County

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman John Joyce, M.D. (PA-13), Chairman of the Energy and Commerce Subcommittee on Oversight and Investigations, Congressman Morgan Griffith (VA-09), Chairman of the Energy and Commerce Subcommittee on Health, Congressman Jason Smith (MO-08), Chairman of the House Committee on Ways and Means, Congressman David Schweikert (AZ-01), Chairman of the Ways and Means Subcommittee on Oversight, and Congressman Vern Buchanan (FL-16), Chairman of the Ways and Means Subcommittee on Health, authored ** a letter ** to the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) requesting a meeting on the concerning evidence detailed in the letter that points to large-scale, ongoing Medicare fraud in Los Angeles County, along with what action is being taken to address the situation.

“The House Committee on Energy and Commerce has an extensive history of digging deeper into matters where program integrity has been compromised. This letter is crucial in our commitment to eliminating waste, fraud, and abuse in federal health care programs,” said Chairmen Guthrie, Joyce, and Griffith. “Republicans have spent much of this Congress furthering legislation to protect our most vulnerable Americans—especially seniors, but our work is not done. Continued oversight is crucial to uphold the integrity of programs that serve our most vulnerable populations. We applaud the ongoing work being conducted by HHS-OIG in cracking down on the fraud that has occurred, and we look forward to addressing the larger-scale scheme that is draining public resources from Americans who need these services the most.”

“Medicare home health and hospice fraud directly undermines the safety and reliability of care for America’s most vulnerable seniors. Auditors have reported an unprecedented jump in home health and hospice fraud in Los Angeles County, California – including one report showing 112 different hospices located at the same physical address. With $1.2 billion in improper payments in home health claims and the Inspector General reporting $198 million in suspected hospice fraud, Gavin Newsom’s California could just as well be another Minnesota,” said Chairman Smith. “The Ways and Means Committee will not hesitate to use our broad oversight authority to get to the bottom of this and protect taxpayers and vulnerable patients against these bad actors.”

BACKGROUND:

Evidence has strongly suggested large-scale Medicare fraud involving home health agencies (HHA) and hospice agencies in Los Angeles County, California, noting that such practices not only drain public resources but also compromise the quality of care provided to patients, especially those most vulnerable populations.

  • The Centers for Medicare and Medicaid Services (CMS) found that the 2023 improper payment error rate for home health claims was 7.7 percent, or about $1.2 billion, in 2023.
  • In terms of hospice care, HHS OIG reported suspected hospice fraud to be an estimated $198.1 million in fiscal year (FY) 2023.
  • CMS has placed HHAs as an area of high risk for Medicare fraud.

Emerging concerns over Medicare fraud in the HHAs and hospice sector highlights heightened activity, specifically in Los Angeles County.

  • From 2019 through June 2023, HHAs in the U.S. decreased from 8,838 to 8,280 (6 percent), while, at the same time, HHAs in Los Angeles County increased from 896 to 1,309 (46 percent).
  • More than 1,400 new Los Angeles County HHAs enrolled in Medicare in the last five years, representing over 50 percent of all HHAs in the state of California and nearly 14 percent of all HHAs in the country.

Based on data from the March 2022 California State Auditor’s Report and from HHS on hospice ownership, Los Angeles County had more than 31 percent of the hospice agencies in the U.S. in 2022.

  • There were approximately 58 million seniors in the U.S. in 2022, with Los Angeles County having approximately 1.49 million seniors (2.5 percent).
  • The report highlighted indicators that included a “rapid, disproportionate growth in the number of hospice agencies” and “excessive geographic clustering of hospice agencies,” noting that 112 different licensed hospice agencies were located at the same physical address.
  • State auditors in California estimated that hospice agencies in Los Angeles County likely overbilled Medicare by $105 million in 2019.

These accounts of widespread fraud occurring in Los Angeles County’s HHAs and hospice agencies have raised concerns about whether home health and hospice Accrediting Organizations (AO) are effectively examining such organizations at the time of their enrollment in Medicare.

  • In November 2024, CMS issued a Quality, Safety, and Oversight memo to surveyors, reminding them to closely inspect hospices’ Medicare enrollment documents to understand changes in ownership and location, but neglecting to encourage AOs to pursue other commonsense antifraud measures.

In April 2025, HHS OIG announced that the Office of Audit Services would compile a report for FY 2026 to identify trends, patterns, and comparisons that could indicate potential vulnerabilities related to new Medicare hospice provider enrollments.

In May 2025, the Health Care Fraud Strike Force—a joint task force of federal, state, and local law enforcement agencies, including HHS OIG—** announced multiple arrests ** following a multi-year investigation into Armenian Organized Crime, which dismantled five hospices in the greater Los Angeles area.

On November 28, 2025, CMS ** announced ** the Calendar Year 2026 Home Health Prospective Payment System Final Rule, providing comments that suggest an interest in addressing the aforementioned accounts of fraud.

Nov 17, 2025
Health

Chairmen Guthrie and Joyce Pen Letter to CMS Following HHS Announcement Decertifying South Florida OPO and Implementing Further Safety Guidelines for the Organ Procurement and Transplant System

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman John Joyce, M.D. (PA-13), Chairman of the Subcommittee on Oversight and Investigations, sent a letter to the Centers for Medicare and Medicaid Services (CMS) requesting a briefing to better understand the Department of Health and Human Services’ (HHS) recent actions and ongoing work to enhance safety within the organ procurement and transplantation system. On Thursday, September 18, 2025, the Department of Health and Human Services (HHS) announced major efforts to improve safety, transparency, and efficiency within the organ procurement and transplantation system, including the decertification of an organ procurement organization (OPO) for the first time in U.S. history. According to the announcement , the decision was made “after an investigation uncovered years of unsafe practices, poor training, chronic underperformance, understaffing, and paperwork errors.” The Committee has a history of ensuring patient safety remains the highest priority in our organ procurement and transplantation system, as evident from the Committee’s work last Congress on organ transplantation and donation issues as well as its oversight this Congress. As a part of its ongoing investigation, the Committee requests that CMS respond to questions, including those related to the decertification of the OPO in South Florida and the prevalence of incidents similar to those outlined in the Health Resources and Services Administration’s (HRSA) investigative report, to ensure patient safety remains a top priority. Read the full letter HERE . “While the Committee applauds efforts taken by CMS to uphold the highest standards of care to which all OPOs are expected to adhere, HHS’s announcement decertifying the Life Alliance Organ Recovery Agency illustrates the urgency of this moment and why the subcommittee is not finished with our oversight of the organ transplant system,” said Chairmen Guthrie and Joyce. “It is our moral obligation as members of Congress to establish safeguards and prevent these harmful practices from persisting further, and we look forward to obtaining answers from the agency about the prevalence of these incidents, as well as how CMS plans to proceed with prioritizing patient safety first and foremost.” Background: During the 118th Congress, the Committee on Energy and Commerce led the passage of the Securing the U.S. Organ Procurement and Transplantation Network Act to both modernize the Organ Procurement and Transplantation Network (OPTN) and allow HRSA to institute a competitive contracting process to find the best contractors for various OPTN functions. This legislation was signed into law on September 22, 2023.  On March 20, 2024, the Committee launched an investigation into the organ procurement and transplantation system by sending a letter to United Network for Organ Sharing (UNOS) requesting information related to concerns surrounding data security and operability, patient safety and equity, and conflicts of interest.   On March 20, 2024, the Committee also sent a letter to HRSA requesting information related to implementation of the Securing the U.S. Organ Procurement and Transplantation Network Act as well as other concerns related to effective oversight and management.  On September 11, 2024, the Subcommittee on Oversight and Investigations held a hearing that focused on the implementation of reforms at the OPTN, including the need for stronger oversight and accountability as well as ongoing patient safety concerns.  During the hearing, questions were raised related to allegations of mismanagement and patient safety concerns after patients began exhibiting signs of increased neurologic function after being previously deemed suitable as an organ donation candidate. Several of these allegations, particularly those related to patient safety, were later substantiated through the findings contained in HRSA’s March 2025 report.  On March 24, 2025, HRSA’s Division of Transplantation issued a report that summarized the findings of its investigation into KYDA, the OPO now known as Network for Hope, which serves Kentucky and parts of Ohio, West Virginia, and Indiana.   HRSA’s investigation examined an “index case” and an additional 351 unique cases of authorized, not recovered (ANR) patients. This means that the patients were considered for donation after circulatory death recovery, but no organs were transplanted. The report showed that nearly 30 percent of the cases “had concerning features.” The concerning features included problems with patient-family interactions, medical assessments and team interactions, recognition of high neurologic function, and recognition and documentation of drugs in records.  On May 28, 2025, HRSA issued a corrective action plan to the OPTN, which directed the OTPN to take specific actions within a specified period of time, including developing a 12-month OPTN monitoring plan for KYDA to address concerns identified. The corrective action plan also requires the OPTN to propose policies for public comment to improve safeguards for potential donation after circulatory death (DCD) patients in the organ procurement process and increase information shared with patient families regarding DCD organ procurement.  On July 22, 2025, the House Committee on Energy and Commerce’s Subcommittee on Oversight and Investigations held a hearing examining concerning practices within our nation’s organ procurement and transplant system that were identified by HRSA’s investigation.  On September 12, 2025, the Committee sent a bipartisan letter to HRSA requesting a briefing on its ongoing oversight of patient safety in our nation’s organ procurement and transplant system. ###

Oct 31, 2025
Commerce, Manufacturing, and Trade

Chairmen Guthrie, Joyce, and Bilirakis Send Letter to NCAA Over Decision to Let Student Athletes Gamble on Professional Sports

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman John Joyce, M.D. (PA-13), Chairman of the Subcommittee on Oversight and Investigations, and Congressman Gus Bilirakis (FL-12), Chairman of the Subcommittee on Commerce, Manufacturing, and Trade, sent a letter to National Collegiate Athletic Association (NCAA) President Charlie Baker following the recent announcement that student athletes and athletic department staff will be allowed to bet on professional sports. KEY EXCERPTS: “The Committee on Energy and Commerce is examining the NCAA’s recent policy change permitting student athletes and athletic department staff to bet on professional sports.” [...] To assist the Committee in its oversight, we request a briefing by no later than November 13, 2025, that addresses the following: Why is the NCAA changing its policy allowing student athletes to bet on professional sports? Has the NCAA conducted any studies, analyses, or reviews of the impact of gambling on student athletes? If so, what are the results? What role did they play in the NCAA’s decision to allow student athletes to bet on professional sports? How does this change allow the NCAA, the conferences, and the member schools to better protect the integrity of college games and encourage healthy habits for student-athletes who choose to engage in betting activities on professional sports? How is the NCAA engaging with athletic conferences, member institutions, and teams to address questions and concerns about this rule change? Amid recent allegations of illegal sports betting among student athletes and concerns expressed by member institutions, is NCAA reconsidering implementation of the policy? What guardrails are in place to prevent the type of illegal sports betting activity that is allegedly occurring in the NCAA and NBA, considering that some student athletes will go on to become professional athletes? Please provide details about any fraudulent, illegal, and alleged betting practices in connection with NCAA players, coaches, and officials, including the actions of NCAA players identified in recent infraction decisions; as well as prior instances, some of which are identified above. Please describe the NCAA’s “layered integrity monitoring program,” for maintaining competition integrity and pursuing sports betting violations. What gaps, if any, are in existing regulations that allow illegal betting schemes to occur in college sports? BACKGROUND: On October 24, 2025, the Committee on Energy and Commerce launched its investigation into sports fixing and illegal gambling after the Federal Bureau of Investigation (FBI) unsealed indictments of current and former NBA players and coaches. An initial announcement stated that, effective November 1, 2025, student athletes and athletic department staff in all three NCAA divisions would be permitted to bet on professional sports. A few days before the policy change was supposed to take effect, the Division I Board of Directors voted to delay implementation of the rule change across all three divisions to November 22, 2025. A recent NCAA press release stated that “enforcement staff has opened investigations into potential sports betting violations by approximately 30 current or former men's basketball student-athletes.” CLICK HERE to read the full letter.